When compared with the female patients, the male patients had a higher prevalence of advanced fibrosis stages (47.6% vs. 39.7%, P = 0.027), an older mean age (54.6 vs. 50.9 years, P<0.001), a higher prevalence of thrombocytopenia (43.7% vs. 36%, P = 0.001), and a lower median ALT level (126 IU/L vs. 143 IU/L, P<0.001). The gene discussed is GPT; the disease is Thrombocytopenia.